Insulin Treatment Prevents LDL from Accelerated Oxidation in Patients with Diabetes
- 1 January 2002
- journal article
- clinical trial
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 9 (6) , 280-287
Abstract
In a study population, we compared the level of malondialdehyde-modified LDL (MDA-LDL) with the concentrations of lipid parameters in serum and found a strong correlation between MDA-LDL and apolipoprotein B (apo B) concentrations. Their interrelations had a turning point at an apo B concentration of 1,150 mg/l. In diabetic patients, the ratio of MDA-LDL/apo B increased at apo B concentrations above 1,150 mg/l. This ratio represents the extent of modification of apo B by MDA. In the control subjects, this ratio remained stable. When we divided the patients into medication groups (statins and insulin), we found that the 1,150 mg/l threshold disappeared. At apo B concentrations above 1,150 mg/l, the ratio of MDA-LDL/apo B in the statin group was as high as that in the non-drug group. In the insulin group, the means of MDA-LDL/apo B in all ranges of apo B levels decreased to an extent statistically indistinguishable from those of the control group. In conclusion, insulin therapy represses LDL oxidation even at apo B concentrations > 1,150 mg/l and should be noted for its anti-oxidation properties.Keywords
This publication has 21 references indexed in Scilit:
- Evidence That Acute Insulin Administration Enhances LDL Cholesterol Susceptibility to Oxidation in Healthy HumansArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Apolipoprotein B-100 Conformation and Particle Surface Charge in Human LDL Subspecies: Implication for LDL Receptor InteractionBiochemistry, 1998
- Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patientsDiabetes, 1997
- The Yin and Yang of Oxidation in the Development of the Fatty StreakArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serumBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- LDL particle size distribution. Results from the Framingham Offspring Study.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozilJournal of Internal Medicine, 1991
- Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritable Hyperlipidemic RabbitsScience, 1988
- In vivo stimulation of low-density lipoprotein degradation by insulinDiabetes, 1984